文献速递青光眼白内障与屈光手术

Baerveldt分流管手术与Baerveldt分流管联合超声乳化术的前瞻性对比研究

Baerveldt shunt surgery versus combined Baerveldt shunt and phacoemulsification: a prospective comparative study.
PubMed 文献 · Br J Ophthalmol · 2017-12-15

前瞻性对比76眼难治性青光眼:38只人工晶状体眼单行Baerveldt管植入(BT),38只晶状体眼行Baerveldt管联合超声乳化(PBT),随访至少36个月。36个月时PBT组失败率37%显著高于BT组15%(P=0.02),PBT组眼压中位数14 mmHg亦显著高于BT组12 mmHg(P=0.04);作者认为联合超声乳化可能对远期滤过泡存活有负面影响。

要点

  • 36个月失败率PBT组37% vs BT组15%,P=0.02,PBT组显著更高。
  • 36个月眼压中位数PBT组14 mmHg vs BT组12 mmHg,P=0.04。
  • 两组术后并发症均为5眼(13% vs 13%),抗青光眼药物数无显著差异(P=0.61)。

核心结论

  • 36个月时PBT组失败率显著高于BT组(37% vs 15%,P=0.02),PBT组眼压中位数亦显著更高(14 mmHg vs 12 mmHg,P=0.04)。
  • 作者认为,将超声乳化与房水引流管手术联合可能对远期引流管滤过泡存活产生负面影响。

研究设计与样本

  • 前瞻性对比研究,纳入76例患者的76只眼,其中38只人工晶状体眼行单纯Baerveldt管植入(BT),38只晶状体眼行Baerveldt管植入联合超声乳化(PBT)。
  • 两组按术前眼压和抗青光眼药物数量匹配,随访至少36个月。
  • 失败定义为眼压控制不佳(眼压≤5 mmHg或>21 mmHg,或较基线下降<20%)、因青光眼再次手术、丧失光感或取出植入物。

主要发现

  • 36个月时失败率PBT组37% vs BT组15%,P=0.02。
  • 术前基线眼部特征PBT组与BT组无显著差异。
  • 36个月时眼压中位数PBT组14 mmHg vs BT组12 mmHg,P=0.04。
  • 36个月时抗青光眼药物平均数PBT组1.7 vs BT组1.3,P=0.61;视力中位数PBT组0.8 vs BT组0.7,P=0.44。
  • 术后并发症发生率两组相似(各5眼,13% vs 13%)。

关键数值与推荐

  • 失败判定标准:眼压≤5 mmHg或>21 mmHg、较基线下降<20%、因青光眼再次手术、丧失光感或取出植入物。
  • 随访时长:至少36个月。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To examine the efficacy and safety of Baerveldt tube (BT) implantation compared with combined phacoemulsification and Baerveldt tube (PBT) implantation in patients with refractory glaucoma. METHODS: Seventy-six eyes of 76 patients were enrolled, 38 pseudophakic eyes underwent BT implantation alone and 38 phakic eyes underwent the BT implantation combined with phacoemulsification. Groups were matched for preoperative intraocular pressure (IOP) and number of glaucoma medications. Preoperative and postoperative measures recorded included patient demographics, visual acuity (VA), IOP, number of antiglaucoma medications and all complications. Patients were followed up for a minimum of 36 months. Failure was defined as: inadequate IOP control (IOP≤5 mm Hg/>21 mm Hg/<20% reduction from baseline, reoperation for glaucoma, loss of light perception vision, or removal of the implant). RESULTS: There was a significant difference in failure rates between groups at 36 months (PBT 37% vs BT 15%, P=0.02). There was no significant difference for PBT versus BT in preoperative baseline ocular characteristics. At 36 months: median IOP=14 mm Hg vs 12 mm Hg, P=0.04; mean number of antiglaucomatous medications=1.7 vs 1.3, P=0.61; median VA=0.8 vs 0.7, P=0.44. Postoperative complication rates were similar in both groups (n=5 vs 5; 13% vs 13%). CONCLUSIONS: Failure rates were significantly greater in the PBT group at 3 years. Median IOP was also significantly higher in the PBT group. These results suggest that combining phacoemulsification with aqueous shunt surgery may have a negative effect on long-term shunt bleb survival.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. El Wardani M, Bergin C, Bradly K, et al. Baerveldt shunt surgery versus combined Baerveldt shunt and phacoemulsification: a prospective comparative study. Br J Ophthalmol. 2017. PMID: 29246892. doi:10.1136/bjophthalmol-2017-310698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。